Commerzbank Aktiengesellschaft FI bought a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 16,364 shares of the financial services provider’s stock, valued at approximately $2,838,000.
A number of other institutional investors have also made changes to their positions in the business. Headlands Technologies LLC bought a new stake in Marsh & McLennan Companies during the 2nd quarter worth about $29,000. Solstein Capital LLC bought a new position in shares of Marsh & McLennan Companies in the fourth quarter worth about $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter worth approximately $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $27,000. Finally, Golden State Wealth Management LLC bought a new position in Marsh & McLennan Companies in the 4th quarter worth approximately $27,000. 87.99% of the stock is owned by institutional investors.
Key Marsh & McLennan Companies News
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: Marsh & McLennan reported second-quarter EPS of $2.96, topping consensus, while revenue rose to $7.28 billion and came in above expectations, signaling solid underlying demand in its consulting and risk & insurance businesses. Article Title
- Positive Sentiment: Management’s earnings call pointed to growth that is holding up better than feared, with consulting and insurance operations supporting results despite a tougher backdrop. Article Title
- Neutral Sentiment: William Blair kept a Hold rating on MRSH, saying the quarter was solid and growth appears to be stabilizing, but the stock’s valuation remains a concern. Article Title
- Neutral Sentiment: The company also announced Q2 2026 earnings and held its investor conference call, reinforcing that the market is still digesting the details of the quarter and management’s outlook. Article Title
- Negative Sentiment: Higher operating expenses and the lack of a major growth re-acceleration may be tempering enthusiasm, helping explain why the stock is trading lower despite the earnings beat. Article Title
Marsh & McLennan Companies Trading Down 0.4%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.89 by $0.07. The business had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%. Sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 10.36 earnings per share for the current year.
Marsh & McLennan Companies Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd will be given a dividend of $0.99 per share. This represents a $3.96 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, July 23rd. This is an increase from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. Marsh & McLennan Companies’s dividend payout ratio is presently 45.00%.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. Bank of America reduced their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a report on Tuesday, April 14th. UBS Group boosted their target price on Marsh & McLennan Companies from $203.00 to $212.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Wells Fargo & Company decreased their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a report on Thursday, April 9th. JPMorgan Chase & Co. lifted their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Finally, Weiss Ratings downgraded shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $200.81.
Read Our Latest Report on MRSH
Insider Activity at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by company insiders.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
